


Searching News Database: Taro Pharmaceutical
HSMN NewsFeed - 24 Jan 2017
Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort(R) Spray, 0.25%
Perrigo Announces FDA Approval Of Its First-To-File AB Rated Generic Version Of Topicort(R) Spray, 0.25%
HSMN NewsFeed - 5 May 2016
Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales
Aclaris Therapeutics, Inc. Appoints Kevin Scott as Vice President of Sales
HSMN NewsFeed - 4 Mar 2016
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business
Cipher Pharmaceuticals Appoints Ralph Bohrer President & General Manager of U.S. Business
HSMN NewsFeed - 31 Jul 2008
Taro and NextWave Announce Agreement to Co-Promote OVIDE(R) in the United States
Taro and NextWave Announce Agreement to Co-Promote OVIDE(R) in the United States
HSMN NewsFeed - 25 Mar 2008
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
Taro Receives FDA Approval for Ondansetron Hydrochloride Injection USP, 2 mg/mL ANDA
HSMN NewsFeed - 22 Jan 2008
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
Taro Receives FDA Approval of New Drug Application for Flo-Pred(TM) (Prednisolone Acetate Oral Suspension)
HSMN NewsFeed - 13 Nov 2006
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
Taro Receives Marketing Authorization in UK for Etopan XL Tablets 600 mg, Etodolac
HSMN NewsFeed - 8 Sep 2006
Taro Announces Filing Of ANDA For Oxcarbazepine Tablets 150, 300 And 600 MG
Taro Announces Filing Of ANDA For Oxcarbazepine Tablets 150, 300 And 600 MG
Additional items found! 15
Members Archive contains
15 additional stories matching:
Taro Pharmaceutical
(Password required)
Taro Pharmaceutical
(Password required)
